Medical News Today (Brighton, United Kingdom, Feb. 15) – By hijacking a cancer cell’s own metabolism, researchers have found a way to tag and target elusive cancers with small-molecule sugars. This opens treatment pathways for cancers that are not responsive to conventional targeted antibodies, such as triple-negative breast cancer. Led by Jianjun Cheng, a Hans Thurnauer Professor of Materials Science and Engineering at the University of Illinois, researchers at Illinois and collaborators in China published their findings in the journal Nature Chemical Biology. Also: Phys.Org (Feb. 14), Chemical and Engineering News (Washington, D.C., Feb. 15), Science Daily (Feb. 15), ScienceBlog (Feb. 15), Science 360 (NSF, Feb. 16).